:::

About

:::

Introduction

Institute of Molecular and Cellular Biology

The IMCB was established in 2002.  To foster cutting-edge research in biological sciences and to translate laboratory hypothesis-driven discoveries into advances in biomedicine and biotechnology, we focus on establishing cellular and animal models to excel in investigations of infectious diseases, neurodegenerative diseases and cancers.  Specific research interests include

    Molecular mechanisms of speciation, conservation and cellular mineralization

    Land plant evolution

    Glycobiology for targeted drug discovery and delivery

    Signal transduction in carcinogenesis

    Axonal and intraflagellar transport in Caenorhabditis elegans

    Pathogenesis of Helicobacter pylori and Candida albicans

    Molecular immunology

    Cancer stem-cell biology and cancer epigenetics

    Virus-mediated genomic instability and tumorigenesis

   Avian evolutionary genetics and genomies

    DNA double strand break repair

 

The IMCB has access to advanced equipment such as a High Throughput Genome Analyzer, cell sorter, and state-of-the art in vivo imaging systems. In addition, we maintain continuous collaboration with international laboratories at Johns Hopkins University (USA), University of Southern California(USA), Oxford University (UK), University of Basel (Switzerland), University of Copenhagen (Denmark), Tsinghua University (China), Xiamen University (China), Yunnan Normal University (China) and more.  Our goals are to become a successful player in the global science league and to train potential leaders in both academics and industry.  Current IMCB members include 15 principal investigators, 3 adjunct professors , 2 postdoctoral researchers and 70 graduate students. IMCB alumni have made outstanding contributions to superb academic research, biotechnology, biomedicine, conservation biology, intellectual property & technology licensing, entrepreneurship as well as science & technology management.
cron web_use_log